Moderna's vaccine candidate has ‘potential' to confer longer-term immunity, company saysMarket Watch • 12/03/20
Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine CandidateBusiness Wire • 12/03/20
What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine CandidatesThe Motley Fool • 12/03/20
Should You Worry About This News in Moderna's Investigational Coronavirus Vaccine Report?The Motley Fool • 12/03/20
Merck sells its $175 million investment stake in Moderna after recording a 'substantial' gain (MRNA)Business Insider • 12/02/20
Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)Seeking Alpha • 12/02/20
Moderna, Inc. (MRNA) Presents at Evercore ISI HealthCONx Broker Conference Call - (Transcript)Seeking Alpha • 12/01/20